logo

Mallinckrodt Plc (MNK)



Trade MNK now with
  Date
  Headline
6/15/2020 11:01:00 AM MNK To Proceed With Appeal Despite Court Decision Denying Injunction In Acthar Gel Medicaid Drug Dispute With CMS
6/15/2020 6:33:01 AM Mallinckrodt To Present Phase 3 StrataGraft Regenerative Skin Tissue Clinical Trial Results During ABA Meeting
6/11/2020 6:49:35 AM Mallinckrodt Publishes Findings To Assess Use Of Terlipressin And Other Vasopressors In Patients With HRS-1
6/9/2020 6:33:16 AM Mallinckrodt Completes Rolling Submission Of BLA For StrataGraft Regenerative Skin Tissue To FDA
6/1/2020 6:55:26 AM Mallinckrodt Plans To Appeal To Overturn District Court Decision
5/5/2020 7:14:47 AM Mallinckrodt Q1 Net Loss $50.2 Mln Vs. Net Income $154.9 Mln Last Year
5/4/2020 6:50:21 AM Mallinckrodt Announces Positive Findings In INOmax Gas, For Inhalation Phase 4 Observational Registry In Neonates
4/22/2020 6:47:46 AM Mallinckrodt Announces FDA Filing Acceptance Of NDA For Terlipressin For Hepatorenal Syndrome Type 1
4/8/2020 8:01:57 AM Linde Says U.S. Supreme Court Upholds Nitric Oxide Patent
4/6/2020 6:46:00 AM Mallinckrodt Initiates Rolling Submission Of BLA For StrataGraft Regenerative Skin Tissue To FDA
4/1/2020 6:54:24 AM Mallinckrodt Get Health Canada Clearance To Start Pilot Trial Of High-Dose Inhaled Nitric Oxide Therapy For COVID-19